Literature DB >> 25412849

Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.

Mahul B Amin1, Steven C Smith1, Victor E Reuter2, Jonathan I Epstein3, David J Grignon4, Donna E Hansel5, Oscar Lin2, Jesse K McKenney6, Rodolfo Montironi7, Gladell P Paner8, Hikmat A Al-Ahmadie2, Ferran Algaba9, Syed Ali3, Isabel Alvarado-Cabrero10, Lukas Bubendorf11, Liang Cheng4, John C Cheville12, Glen Kristiansen13, Richard J Cote14, Brett Delahunt15, John N Eble4, Elizabeth M Genega16, Christian Gulmann17, Arndt Hartmann18, Cord Langner19, Antonio Lopez-Beltran20, Cristina Magi-Galluzzi6, Jorda Merce14, George J Netto3, Esther Oliva21, Priya Rao22, Jae Y Ro23, John R Srigley24, Satish K Tickoo2, Toyonori Tsuzuki25, Saleem A Umar14, Theo Van der Kwast26, Robert H Young21, Mark S Soloway14.   

Abstract

The International Consultations on Urological Diseases are international consensus meetings, supported by the World Health Organization and the Union Internationale Contre le Cancer, which have occurred since 1981. Each consultation has the goal of convening experts to review data and provide evidence-based recommendations to improve practice. In 2012, the selected subject was bladder cancer, a disease which remains a major public health problem with little improvement in many years. The proceedings of the 2nd International Consultation on Bladder Cancer, which included a 'Pathology of Bladder Cancer Work Group,' have recently been published; herein, we provide a summary of developments and consensus relevant to the practicing pathologist. Although the published proceedings have tackled a comprehensive set of issues regarding the pathology of bladder cancer, this update summarizes the recommendations regarding selected issues for the practicing pathologist. These include guidelines for classification and grading of urothelial neoplasia, with particular emphasis on the approach to inverted lesions, the handling of incipient papillary lesions frequently seen during surveillance of bladder cancer patients, descriptions of newer variants, and terminology for urine cytology reporting.

Entities:  

Mesh:

Year:  2014        PMID: 25412849      PMCID: PMC5009623          DOI: 10.1038/modpathol.2014.158

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  70 in total

1.  Transitional cell carcinoma with rhabdoid features.

Authors:  S Kumar; D Kumar; D F Cowan
Journal:  Am J Surg Pathol       Date:  1992-05       Impact factor: 6.394

Review 2.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

3.  Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference.

Authors:  Mahul B Amin; Kiril Trpkov; Antonio Lopez-Beltran; David Grignon
Journal:  Am J Surg Pathol       Date:  2014-08       Impact factor: 6.394

4.  Uroplakin II outperforms uroplakin III in diagnostically challenging settings.

Authors:  Steven C Smith; Sambit K Mohanty; Lakshmi P Kunju; Elena Chang; Fai Chung; Jason C Carvalho; Gladel P Paner; Donna E Hansel; Daniel J Luthringer; Mariza N de Peralta-Ventrurina; Mahul B Amin
Journal:  Histopathology       Date:  2014-02-25       Impact factor: 5.087

5.  Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases.

Authors:  Adam D Toll; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2012-07       Impact factor: 6.394

6.  Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.

Authors:  Keith E Volmar; Theresa Y Chan; Angelo M De Marzo; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2003-09       Impact factor: 6.394

7.  Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.

Authors:  H Samaratunga; K Khoo
Journal:  Histopathology       Date:  2004-07       Impact factor: 5.087

8.  Inverted variant of urothelial carcinoma of the urinary bladder: a report of three cases and a proposal for a new clinicopathologic entity.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

9.  Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

Authors:  Ashish M Kamat; Colin P N Dinney; Jason R Gee; H Barton Grossman; Arlene O Siefker-Radtke; Pheroze Tamboli; Michelle A Detry; Tracy L Robinson; Louis L Pisters
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860

Review 10.  The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?

Authors:  Jonathan I Epstein
Journal:  Crit Rev Oncol Hematol       Date:  2003-08       Impact factor: 6.312

View more
  30 in total

1.  Invasive urothelial carcinoma with chordoid features of the ureter: a rare entity and review of literature.

Authors:  Jianguo Wei; Zhenying Yue; Dianhang Song; Qiang Wang; Xiaodong Teng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 2.  Cell-free DNA in blood and urine as a diagnostic tool for bladder cancer: a meta-analysis.

Authors:  Xin-Shuai Wang; Meng-Qi Zhao; Li Zhang; De-Jiu Kong; Xue-Zhen Ding; Xiao-Chen Hu; Jun-Qiang Yang; She-Gan Gao
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 3.  A practical guide to bladder cancer pathology.

Authors:  Eva Compérat; Justine Varinot; Julien Moroch; Caroline Eymerit-Morin; Fadi Brimo
Journal:  Nat Rev Urol       Date:  2018-01-31       Impact factor: 14.432

Review 4.  Bladder cancer: Active surveillance for low-grade Ta bladder tumours.

Authors:  Mark S Soloway
Journal:  Nat Rev Urol       Date:  2016-02-16       Impact factor: 14.432

5.  Dataset for the reporting of carcinoma of the bladder-cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  E Compérat; J R Srigley; F Brimo; B Delahunt; M Koch; A Lopez-Beltran; V Reuter; H Samaratunga; J H Shanks; T Tsuzuki; T van der Kwast; M Varma; F Webster; D Grignon
Journal:  Virchows Arch       Date:  2020-01-08       Impact factor: 4.064

Review 6.  Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.

Authors:  Giulia Brisotto; Roberto Guerrieri; Francesca Colizzi; Agostino Steffan; Barbara Montico; Elisabetta Fratta
Journal:  Methods Mol Biol       Date:  2021

7.  β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer.

Authors:  Georgios Kallifatidis; Diandra K Smith; Daley S Morera; Jie Gao; Martin J Hennig; James J Hoy; Richard F Pearce; Isha R Dabke; Jiemin Li; Axel S Merseburger; Markus A Kuczyk; Vinata B Lokeshwar; Bal L Lokeshwar
Journal:  Mol Cancer Ther       Date:  2019-02-20       Impact factor: 6.261

8.  High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.

Authors:  Doreen Nguyen; Diana Taheri; Simeon Springer; Morgan Cowan; Gunes Guner; Maria Angelica Mendoza Rodriguez; Yuxuan Wang; Isaac Kinde; Christopher J VandenBussche; Matthew T Olson; Bernardo F P Ricardo; Isabela Cunha; Kazutoshi Fujita; Dilek Ertoy; Kenneth W Kinzler; Trinity J Bivalacqua; Nickolas Papadopoulos; Bert Vogelstein; George J Netto
Journal:  Virchows Arch       Date:  2016-08-12       Impact factor: 4.064

Review 9.  The pathology of urinary bladder lesions with an inverted growth pattern.

Authors:  Aitao Guo; Aijun Liu; Xiaodong Teng
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

Review 10.  Molecular and histopathology directed therapy for advanced bladder cancer.

Authors:  Constantine Alifrangis; Ursula McGovern; Alex Freeman; Thomas Powles; Mark Linch
Journal:  Nat Rev Urol       Date:  2019-07-09       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.